-
Catalogue Entry: Indoor Air Carbon Monoxide (CO) summary statistics
Langan Model T15n Enhanced CO monitor has been used by Water and Air Quality Bureau to measure carbon monoxide levels across Canada. This table is a summary of carbon monoxide...-
File available for download in the following formats:
- CSV
-
Catalogue Entry: Summary Safety Review - ESSURE Permanent Birth Control System - Assessing...
Health Canada carried out a safety review due to concerns regarding complications associated with the Essure device after it is inserted into the fallopian tubes. In certain...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Ear and Forehead (contact) Infrared Thermometers...
Health Canada reviewed the risk of IR thermometers being inaccurate when checking the temperature of children under 2 years old because of new information that became available....-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) Inhibitors - Assessing...
A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use of DPP-4 inhibitors as a follow-up to a risk communication released...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - DICLECTIN (doxylamine and pyridoxine combination) -...
Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of Diclectin was recently reviewed by Health Canada as...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Denosumab (Prolia and Xgeva) - Hearing loss and deafness
A safety review was carried out after Health Canada received a report from the European Medicines Agency, which linked hearing loss and deafness to the use of Prolia and Xgeva....-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Codeine-containing products - Further Assessing the...
In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of potentially life-threatening breathing problems. At the...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough -...
Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to be converted to morphine faster and more completely...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Clozapine - Assessing the effectiveness of...
Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not helped. Clozapine was developed in the 1960s. In...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Celecoxib - Assessing the Risk of Serious Heart and...
Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related to heart and stroke linked with celecoxib, in comparison to...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Breast Implants - Assessing the potential risk of...
Health Canada has completed a safety review on the potential risk of BIA-ALCL, following an increase in the number of cases reported internationally. The review analysed the...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of...
Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in Europe that warn about the risk...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Benzodiazepines and barbiturates - Assessing the...
The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian product safety information for phenobarbital...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential...
Health Canada reviewed the potential risk of colitis with Aubagio use after finding reports (since being marketed) of colitis as part of routine review of information received...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Atypical antipsychotics - Assessing the Potential...
Health Canada carried out a safety review to look into the use of atypical antipsychotics and the potential risk of having difficulty urinating or not being able to fully empty...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Atypical antipsychotics - Assessing the potential...
Health Canada reviewed the potential risk of SW and SRED with the use of atypical antipsychotics, following the publication of a case report describing these events in a patient...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Atypical antipsychotics - Assessing the Potential...
Health Canada carried out a safety review to look into the risk of sleep apnoea with the use of atypical antipsychotics. Sleep apnoea is a disorder that causes breaks in...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Atypical antipsychotics - Assessing the potential...
Health Canada reviewed the potential risk of DRESS with the use of atypical antipsychotics, following the manufacturers’ voluntary update of the product safety information for...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Antidepressants - Assessing the Potential Risk of...
Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure glaucoma linked to antidepressant use. Angle-closure...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Alpha Lipoic Acid - Assessing the Potential Risk of...
This safety review was carried out by Health Canada after the publication of case reports of IAS (insulin autoimmune syndrome) causing hypoglycemic episodes linked with the use...-
File available for download in the following formats:
- HTML